WHO's 'priority pathogens' list highlights urgent need for new drugs
CBC | Health News
The World Health Organization releases its first list of priority pathogens — superbugs that have developed resistance to existing antibiotics. It's a call to action for the world's scientists and drug companies. But those on the front lines say the challenges are daunting.
Longtime landlord Darryl Spencer was left scrambling for insurance after discovering a tenant was growing dozens of medical marijuana plants inside and outside his rental house.
Health - CBSNews.com
New research shows how mothers struggle with sleep deprivation. Sixty-two percent of women aged 45 and younger who don't have children report getting at least seven hours of sleep per night, but that number drops to 48 percent for mothers. Dr. Carol Ash, director of sleep medicine at Meridian Health in New Jersey, joins "CBS This Morning" to discuss the findings.
FOX News
A pregnant mom has spoken of her heartbreak after discovering that her unborn daughter’s organs were growing on the outside of her body.
As March rolls around, your New Year’s weight loss resolutions may be in the rearview mirror.
Trader Joe’s has issued a voluntary recall for variations of an unsweetened apple sauce over concerns about possible pieces of glass in the products’ jars.
With many poultry markets closed in the wake of China's worst-ever bird flu outbreak, local egg producers are being forced to shell out to feed and water chickens long after they would normally have been killed and sold for meat.
Health and Fitness Articles from EzineArticles.com
Wondering what good can alkaline water do to your body? Check this easy guide to know everything that is essential about this popular concept.
Reuters: Health News
LONDON, (Reuters) - - New antibiotics need to be developed urgently to combat 12 families of bacteria, the World Health Organization said on Monday, describing these "priority pathogens" as the greatest threats to human health.
(Reuters) - La Jolla Pharmaceutical Co's shares surged as much as 76.8 percent on Monday after the company said its drug to treat low blood pressure succeeded in a key trial, taking it one step closer to bringing its first drug to market.
No comments:
Post a Comment